These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 23321667)
21. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1. Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036 [TBL] [Abstract][Full Text] [Related]
22. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. He YM; Xiao YS; Wei L; Zhang JQ; Peng CH J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277 [TBL] [Abstract][Full Text] [Related]
23. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway. Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061 [TBL] [Abstract][Full Text] [Related]
24. The long noncoding RNA HOTTIP promotes breast cancer cell migration, invasiveness, and epithelial-mesenchymal transition via the Wnt-β-catenin signaling pathway. Han S; Jin X; Liu Z; Xing F; Han Y; Yu X; He G; Qiu F Biochem Cell Biol; 2019 Oct; 97(5):655-664. PubMed ID: 30676763 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells. Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847 [TBL] [Abstract][Full Text] [Related]
26. Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer. Wang B; Tang Z; Gong H; Zhu L; Liu X Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054966 [TBL] [Abstract][Full Text] [Related]
27. BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10. Gong C; Qu S; Lv XB; Liu B; Tan W; Nie Y; Su F; Liu Q; Yao H; Song E Nat Commun; 2014 Nov; 5():5406. PubMed ID: 25406648 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression. Liu F; Liu Y; Shen J; Zhang G; Han J Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393 [TBL] [Abstract][Full Text] [Related]
29. Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/β-catenin signaling. Li Y; Yan X; Shi J; He Y; Xu J; Lin L; Chen W; Lin X; Lin X BMC Cancer; 2019 May; 19(1):505. PubMed ID: 31138169 [TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway. Li GH; Ma ZH; Wang X Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709 [TBL] [Abstract][Full Text] [Related]
31. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway. Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584 [TBL] [Abstract][Full Text] [Related]
32. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway. Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987 [TBL] [Abstract][Full Text] [Related]
33. Upregulation of Wnt5a promotes epithelial-to-mesenchymal transition and metastasis of pancreatic cancer cells. Bo H; Zhang S; Gao L; Chen Y; Zhang J; Chang X; Zhu M BMC Cancer; 2013 Oct; 13():496. PubMed ID: 24156409 [TBL] [Abstract][Full Text] [Related]
34. 3,5,4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Tsai JH; Hsu LS; Lin CL; Hong HM; Pan MH; Way TD; Chen WJ Toxicol Appl Pharmacol; 2013 Nov; 272(3):746-56. PubMed ID: 23921149 [TBL] [Abstract][Full Text] [Related]
35. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
36. miR-373-3p Targets DKK1 to Promote EMT-Induced Metastasis via the Wnt/ Weng J; Zhang H; Wang C; Liang J; Chen G; Li W; Tang H; Hou J Biomed Res Int; 2017; 2017():6010926. PubMed ID: 28337453 [TBL] [Abstract][Full Text] [Related]
37. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells. Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348 [TBL] [Abstract][Full Text] [Related]
38. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway. Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851 [TBL] [Abstract][Full Text] [Related]
39. EphA2 promotes epithelial-mesenchymal transition through the Wnt/β-catenin pathway in gastric cancer cells. Huang J; Xiao D; Li G; Ma J; Chen P; Yuan W; Hou F; Ge J; Zhong M; Tang Y; Xia X; Chen Z Oncogene; 2014 May; 33(21):2737-47. PubMed ID: 23752181 [TBL] [Abstract][Full Text] [Related]
40. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway. Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]